Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-α gene promoter polymorphisms

Journal of Gastroenterology and Hepatology (Australia)

Volumn 21, Issue 7, 2006, Pages 1163-1169

  Cheong, Jae Youn ^a   Cho, Sung Won ^a   Hwang, Il Lan ^a   Yoon, Seung Kew ^b   Lee, June Hyuk ^c   Park, Choon Sik ^c   Lee, Jong Eun ^d   Hahm, Ki Baik ^a   Kim, Jin Hong ^a  

^a Ajou University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c DNA Link Inc   (South Korea)

^d Soonchunhyang University   (South Korea)

Author keywords

Chronic hepatitis B; Interleukin 10 (IL 10); Single nucleotide polymorphism (SNP); Tumor necrosis factor (TNF )

Indexed keywords

INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HOMOZYGOSITY; HUMAN; KOREA; LIVER CIRRHOSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVARIATE ANALYSIS;

EID: 33745219475     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04304.x     Document Type: Article

References (26)

1. Lee WM. Hepatitis B virus infection. N. Engl. J. Med. 1997 337 : 1733 45.
2. Shimbo S Zhang ZW Qu JB et al. Urban-rural comparison of HBV and HCV infection prevalence among adult women in Shandong Province, China. Southeast Asian J. Trop. Med. Public Health 1997 28 : 500 6.
3. Thursz MR Kwiatkowski D Allsopp CE Greenwood BM Thomas HC Hill AV. Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N. Engl. J. Med. 1995 332 : 1065 9.
4. Hohler T Gerken G Notghi A et al. HLA-DRB1*1301 and *1302 protect against chronic hepatitis B. J. Hepatol. 1997 26 : 503 7.
5. Guidotti LG Ando K Hobbs MV et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl Acad. Sci. USA 1994 91 : 3764 8.
6. Rico MA Quiroga JA Subira D et al. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology 2001 33 : 295 300.
7. Ben-Ari Z Mor E Papo O et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am. J. Gastroenterol. 2003 98 : 144 50.
8. Miyazoe S Hamasaki K Nakata K et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am. J. Gastroenterol. 2002 97 : 2086 92.
9. Moore KW de Waal Malefyt R Coffman RL O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001 19 : 683 765.
10. Eskdale J Keijsers V Huizinga T Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun. 1999 1 : 151 5.
11. Edwards-Smith CJ Jonsson JR Purdie DM Bansal A Shorthouse C Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 1999 30 : 526 30.
12. Yee LJ Tang J Gibson AW Kimberly R Van Leeuwen DJ Kaslow RA. Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 2001 33 : 708 12.
13. Wilson AG Symons JA McDowell TL McDevitt HO Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc. Natl Acad. Sci. USA 1997 94 : 3195 9.
14. Hohler T Kruger A Gerken G Schneider PM Meyer zum Buschenefelde KH Rittner C. A tumor necrosis factor-alpha (TNF-alpha) promoter polymorphism is associated with chronic hepatitis B infection. Clin. Exp. Immunol. 1998 111 : 579 82.
15. Syvanen AC. From gels to chips: 'minisequencing' primer extension for analysis of point mutations and single nucleotide polymorphisms. Hum. Mutat. 1999 13 : 1 10.
16. Shin HD Park BL Kim LH et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum. Mol. Genet. 2003 12 : 901 6.
17. Ahn SH Han KH Park JY et al. Association between hepatitis B virus infection and HLA-DR type in Korea. Hepatology 2000 31 : 1371 3.
18. Thio CL Carrington M Marti D et al. Class II HLA alleles and hepatitis B virus persistence in African Americans. J. Infect. Dis. 1999 179 : 1004 6.
19. Almarri A Batchelor JR. HLA and hepatitis B infection. Lancet 1994 344 : 1194 5.
20. Thio CL Thomas DL Carrington M. Chronic viral hepatitis and the human genome. Hepatology 2000 31 : 819 27.
21. Kim YJ Lee HS Yoon JH et al. Association of TNF-alpha promoter polymorphisms with the clearance of hepatitis B virus infection. Hum. Mol. Genet. 2003 12 : 2541 6.
22. Cho IH Song JY Kim DK et al. Prevalence of HBV genotypes in Korean patients with chronic hepatitis B. Korean J Hepatol. 2001 7 : 381 6.
23. Groux H Bigler M de Vries JE Roncarolo MG. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells. J. Immunol. 1998 160 : 3188 93.
24. Santin AD Hermonat PL Ravaggi A et al. Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes. J. Virol. 2000 74 : 4729 37.
25. Gesser B Leffers H Jinquan T et al. Identification of functional domains on human interleukin 10. Proc. Natl Acad. Sci. USA 1997 94 : 14620 5.
26. Vilcek J Lee TH. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 1991 266 : 7313 16.